Sponsor or institution
Clinical trials and research at Second Xiangya Hospital of Central South University
As of November 12, 2026, Find a Trial lists 31 clinical trials run by Second Xiangya Hospital of Central South University that are recruiting, in China. 2 were first registered in the last 30 days. By phase: Phase 1 (4), Phase 2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 31Clinical trials
- 2New in 30 days
- 1Country
Newest trials
All recruiting trials (31)
-
Propranolol with Toripalimab and Platinum Chemo before/around surgery in NSCLC
This study tests whether adding propranolol to toripalimab and platinum-based chemotherapy is safe and tolerable for people with resectable non-small cell lung cancer before surgery.
-
Propranolol with Adebrelimab and Platinum Chemotherapy in Small Cell Lung Cancer
This early-phase trial tests whether adding propranolol to adebrelimab plus platinum chemotherapy is safe and may help treat small cell lung cancer in adults.
-
Environmental factors and Type 1 diabetes risk in China
This observation study tests how environmental factors may influence Type 1 diabetes risk in China, including patients, healthy controls, and relatives.
-
dTMS to reduce antipsychotic-induced weight gain in schizophrenia
A non-invasive brain stimulation test to see if deep TMS can help reduce weight gain in people with schizophrenia who are on antipsychotics.
-
Using accelerated dTMS to help with antipsychotic-related weight gain in schizophrenia
A randomized, sham-controlled trial tests whether accelerated dTMS can reduce weight gain caused by antipsychotic drugs in people with schizophrenia.
-
Brain activity patterns in people with hidradenitis suppurativa and how treatments may relate to changes
This study tests whether adults with hidradenitis suppurativa show different resting brain activity than healthy people and whether these brain patterns relate to symptoms like pain and mood, and whether they change after 3 months of standard biologic or small-molecule treatment.
-
Genetic risk score and progression to insulin in type 1 diabetes
This study tests whether a genetic risk score can predict which people with type 1 diabetes will need insulin progression over three years.
-
Nanocrystalline megestrol acetate with chemoradiation for locally advanced cervical cancer
This Phase 1 trial tests whether taking nanocrystalline megestrol acetate by mouth can prevent or reduce weight and muscle loss in adults with locally advanced cervical cancer who are receiving concurrent chemoradiotherapy.
-
Mobile health and wearables to help manage and prevent diabetes complications
This study tests an AI-based risk model and a smartphone–wearable lifestyle program to help adults with type 2 diabetes see if complications can be predicted and prevented.
-
Hybrid closed-loop insulin control for surgical patients on short-term parenteral nutrition
This trial tests whether a hybrid closed-loop insulin system keeps blood sugar more stable than conventional insulin pumps with continuous glucose monitoring in adults with type 2 diabetes who need surgery and short-term parenteral nutrition.
-
Attapulgite for weight management in adults with obesity
This study will test whether taking attapulgite can safely help adults with obesity, including overweight adults with type 2 diabetes, lose weight or improve blood sugar control.
-
Glycemic Improvement Project (GLITTER) for Type 1 Diabetes: a comprehensive management program
This project will test whether combining dedicated T1D care teams, diabetes technology, structured education, and peer support helps people with type 1 diabetes aged 6 and older improve blood sugar control and psychological well-being.
-
Improving blood sugar control in type 1 diabetes using team care, technology, education and peer support
This program will try whether combining a care team, diabetes technologies (like CGMs and pumps), structured education, and peer support helps people with type 1 diabetes manage their blood sugar better.
-
Exploring how sleep disturbances affect lung cancer treatment outcomes
This study is trying to see how sleep problems affect the success of immune treatments in people with lung cancer.
-
ctDNA‑MRD guided Ivonescimab plus docetaxel versus standard care for advanced NSCLC after long immunotherapy benefit
This trial tests whether adding Ivonescimab with docetaxel, guided by ctDNA minimal residual disease (MRD), can help people with advanced NSCLC who had a long benefit from first‑line immunotherapy but are now MRD‑positive.
-
Using interleukin-2 to treat chronic spontaneous urticaria
This study is testing if a new treatment using interleukin-2 can help adults with moderate to severe chronic hives who haven't found relief from regular allergy medicines.
-
Thrombus removal during PCI after thrombolysis for STEMI
This trial will test whether removing clots during PCI improves outcomes for people with STEMI who received thrombolysis and have a high thrombus burden.
-
Exploring brain structure and gene expression in mental disorders
This study looks at how brain structure and genes relate to schizophrenia and other mental disorders in young people to better understand these conditions.
-
Effects of fecal microbiota transplantation on cognitive function in type 1 diabetes
This study is testing if a treatment using donated stool can help improve thinking skills in people with long-term type 1 diabetes.
-
Precision medicine program for diabetes in China
This study is testing a new way to better classify and diagnose diabetes in patients in China to help create more personalized treatment plans.
-
Combining Propranolol with Sintilimab and Chemotherapy for Advanced Lung Cancer
This study is testing whether adding a heart medication called propranolol to a cancer drug and chemotherapy can help people with advanced lung cancer feel better and live longer.
-
Impact of chronic stress on immunotherapy effectiveness in esophageal cancer patients
This study looks at how ongoing stress might affect the success of immune therapy in people with esophageal cancer who are just starting treatment.
-
Health Improvement Program for Osteoporosis in China
This study is trying to find out how well a tool for predicting fracture risks works for people over 40 with osteoporosis in China, to help improve their treatment and care.
-
Using ctDNA testing and AI to improve treatment predictions for lung cancer
This study is testing if using blood tests for tumor DNA along with AI can help doctors better predict how well a new treatment works for patients with lung cancer that can be surgically removed.
-
Understanding why some lung cancer patients don't respond to new treatments
This study is trying to understand why some patients with advanced lung cancer don't respond to new treatments so that doctors can better tailor therapies to help them.
-
Observational study on fulminant type 1 diabetes in China
This study is trying to learn more about fulminant type 1 diabetes by looking at the health data of patients experiencing it for the first time and comparing it to healthy individuals.
-
Nationwide registry for type 1 diabetes in China
This study is creating a detailed registry for young people with type 1 diabetes in China to better understand their health and challenges.
-
Exploring how psychological stress affects lung cancer treatment outcomes
This study is trying to see how psychological stress affects the success of immune treatments for different types of lung cancer patients.
-
Understanding long-term effects of Type 1 Diabetes in patients
This study is trying to learn more about the long-term effects of Type 1 Diabetes in people who have had it for at least 10 years, by looking at their health data over three years.
-
Evaluating SBRT for treating lung nodules after surgery
This study is testing if Stereotactic Body Radiation Therapy (SBRT) can safely help people with leftover lung nodules after surgery when more surgery isn't possible.
-
Collaborative research on managing Type 1 Diabetes in China
This study is trying to improve the care and treatment of people with Type 1 Diabetes in China by using new technology and education to help manage their condition better.
Quick answers
How many clinical trials run by Second Xiangya Hospital of Central South University are recruiting right now?
31, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.